Israelis show why chronic stress leads to disease
Constant low levels of cortisol destroy normal regulation of the immune system, putting stressed-out people at risk of autoimmune disorders.
Constant low levels of cortisol destroy normal regulation of the immune system, putting stressed-out people at risk of autoimmune disorders.
A significant Israeli study shows how it’s possible to restore a balance of key proteins in brains affected by the disease.
Israeli-made ‘In the Armchair with Picasso’ art kit is getting interest from geriatric professionals around the world.
Israeli study shows that doctors with good personal preventive health habits seem to inspire their patients to follow their example.
Hospital Tampa is the latest US health center to adopt the Israeli-made technology that helps avoid adverse patient events.
Looking for an effective strategy against a particularly deadly form of breast cancer, Weizmann scientists have a potential winner.
GE is banking on Oxitone wrist monitor to provide a heads-up for someone to get medical assistance before it’s too late.
In the not-so-distant future, people blinded by retinitis pigmentosa may be using Israeli technology to see beyond shadows once again.
New EU-funded international study of Mediterranean plants finds Israel’s medicinal herbs effective in fighting bacteria, fungus and infection.
BioHug’s Israeli pressure garment provides custom soothing for people with autism, PTSD and others prone to high stress.
Peel-and-place Bodywell Chip drastically reduces the body’s absorption of radio frequency waves coming from mobile devices.
The field of biogerontology has roots in Israel, and recently world experts gathered here to compare their latest exciting findings.
India-Israel collaboration to commercialize research in healthcare, pharmaceuticals, clean-tech, food security, the environment, engineering and software.
The world’s only third-generation inoculation against this widespread virus comes from an Israeli pharmaceutical company.
The Israeli company’s solutions for enhancing bladder cancer and incontinence medications are expected to be ready next year.